These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23447575)

  • 1. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
    Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
    Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
    Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
    Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway.
    Hua B; Li Y; Yang X; Niu X; Zhao Y; Zhu X
    Biomed Pharmacother; 2020 May; 125():109994. PubMed ID: 32092817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEDDylation controls the target specificity of E2F1 and apoptosis induction.
    Aoki I; Higuchi M; Gotoh Y
    Oncogene; 2013 Aug; 32(34):3954-64. PubMed ID: 23001041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity.
    Ozaki T; Okoshi R; Ono S; Kubo N; Nakagawara A
    Biochem Biophys Res Commun; 2009 Sep; 387(1):143-8. PubMed ID: 19576172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.
    Meier C; Hardtstock P; Joost S; Alla V; Pützer BM
    Cancer Res; 2016 Jan; 76(2):197-205. PubMed ID: 26554827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73.
    Peirce SK; Findley HW
    Int J Oncol; 2009 May; 34(5):1395-402. PubMed ID: 19360352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.
    Yang SZ; Lin FT; Lin WC
    EMBO Rep; 2008 Sep; 9(9):907-15. PubMed ID: 18660752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
    Chen W; Yang Y; Chen B; Lu P; Zhan L; Yu Q; Cao K; Li Q
    J Neurooncol; 2014 Oct; 120(1):43-53. PubMed ID: 25139024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1.
    Wu S; Murai S; Kataoka K; Miyagishi M
    Biochem Biophys Res Commun; 2008 Jan; 365(1):75-81. PubMed ID: 17980704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.
    Testoni B; Schinzari V; Guerrieri F; Gerbal-Chaloin S; Blandino G; Levrero M
    Oncogene; 2011 Jun; 30(23):2670-8. PubMed ID: 21399658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.
    Al-Bahlani S; Fraser M; Wong AY; Sayan BS; Bergeron R; Melino G; Tsang BK
    Oncogene; 2011 Oct; 30(41):4219-30. PubMed ID: 21516125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas.
    Harr MW; Graves TG; Crawford EL; Warner KA; Reed CA; Willey JC
    Mol Cancer; 2005 Jul; 4():23. PubMed ID: 16014176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM; Bhattacharya S; Johnson LR
    Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
    Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
    Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms, function and clinical applications of DNp73.
    Di C; Yang L; Zhang H; Ma X; Zhang X; Sun C; Li H; Xu S; An L; Li X; Bai Z
    Cell Cycle; 2013 Jun; 12(12):1861-7. PubMed ID: 23708520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.